Skip to main content

Table 1 Cohorts included in Asthma BRIDGE. Continuous variables are reported as means with (+/− standard deviation). Binary variables are reported as counts with (percentage of cohort)

From: Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy

 

GRAAD

CAG

CARE

p-value

N

35

25

58

 

CACS

13.97 (+/− 8.01)

12.83 (+/− 6.38)

8.12 (+/− 5.16)

5.70E-05

Age

42.94 (+/− 12.70)

38.52 (+/− 13.35)

13.49 (+/− 3.45)

1.30E-29

Sex (# Male)

9 (25.71%)

6 (24.00%)

40 (68.97%)

1.10E-05

Race

 Non-Hispanic White

0 (0.00%)

4 (16.00%)

35 (60.34%)

2.00E-09

 African American

30 (85.71%)

20 (80.00%)

8 (13.79%)

3.70E-13

 Hispanic

0 (0.00%)

0 (0.00%)

9 (15.52%)

0.0065

 Other/Mixed

5 (14.29%)

1 (4.00%)

6 (10.34%)

0.43

 Age Asthma Onset

18.25 (+/− 16.22)

5.73 (+/−  7.79)

2.16 (+/− 2.09)

1.50E-11

 Atopy

12 (34.29%)

9 (36.00%)

34 (58.62%)

0.036

 Intra-Uterine Smoke

5 (14.29%)

5 (20.00%)

3 (5.17%)

0.11

 Environmental Smoke Exposure

21 (60.00%)

12 (48.00%)

9 (15.52%)

2.80E-05

 Ever Smoker

13 (37.14%)

3 (12.00%)

0 (0.00%)

2.60E-06

  1. P-values for continuous outcomes are from ANOVA, binary outcomes are from chi-squared tests. CACS: Chronic Asthma Control Score. CARE: Childhood Asthma Research and Education study. CAG: Chicago Asthma Genetics study. GRAAD: Genomic Research on Asthma in the African Diaspora